In This Section


  • Temple University Hospital Earns American Heart Association's Get With The Guidelines®–Stroke Gold Plus Quality Achievement Award

    (Philadelphia, PA) – Temple University Hospital has earned the American Heart Association/American Stroke Association’s Get With The Guidelines®–Stroke Gold Plus Quality Achievement Award. The award recognizes Temple University Hospital’s commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment for at least 24 months according to nationally accepted standards and recommendations.

  • Two Temple University School of Medicine Faculty Members Selected for Prestigious NIH Posts

    (Philadelphia, PA) – Joseph Cheung, MD, PhD, Senior Associate Dean for Research and Professor of Medicine at Temple University School of Medicine, and Xiao-Feng Yang, MD, PhD, Professor of Pharmacology, Professor at the Cardiovascular Research Center and Professor at the Sol Sherry Thrombosis Research Center at Temple University School of Medicine, have been selected for prestigious posts as members of National Institutes of Health (NIH) study sections.

  • Temple Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Related to Active Ingredient in Marijuana

    HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy. But researchers at Temple University School of Medicine's Department of Pathology and Laboratory Medicine and Center for Substance Abuse Research (CSAR) recently discovered that synthetic anti-inflammatory substances distantly related to the active ingredient of marijuana may be able to take the punch out of HIV while inside one of its major hideouts – immune cells known as macrophages.

  • Clues to Heart Disease in Unexpected Places, Temple Researchers Discover

    A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented with new medicines. Now, the researchers are one step closer to achieving that goal, thanks to their discovery of a key molecule in an unexpected place in heart cells – mitochondria, tiny energy factories that house the controls capable of setting off cells' self-destruct sequence.

  • Temple Establishes Institute for Population Health

    (Philadelphia, PA) – The Temple University Health System (TUHS) has established an Institute for Population Health, which will further solidify Temple’s commitment to developing innovative programs to enhance the health of individuals and populations, while increasing healthcare quality and lowering its cost.

  • Temple University School of Medicine Ranked as One of the Nation's Top Medical Schools by U.S. News & World Report

    Temple University School of Medicine (TUSM) is once again listed as one of the top research-oriented medical schools in the nation in U.S. News & World Report’s Best Medical Schools 2014 rankings. Temple had the second-highest ranking of all medical schools in Philadelphia.

    TUSM earned its ranking by exhibiting excellence in a number of measures including student admission selectivity, research activity, and its reputation among peer institutions and residency directors.

  • Temple Researchers Discover Key to Heart Failure, New Therapies on Horizon

    Some 5.8 million Americans suffer from heart failure, a currently incurable disease. But scientists at Temple University School of Medicine’s (TUSM) Center for Translational Medicine have discovered a key biochemical step underlying the condition that could aid the development of new drugs to treat and possibly prevent it.

  • Temple Scientists Find Cervical Cancer-Causing Virus In The Brain, Show Potential Connection To Epilepsy

    Researchers at Shriners Hospitals Pediatric Research Center at the Temple University School of Medicine and the University of Pennsylvania have evidence linking the human papillomavirus 16 (HPV16) – the most common cause of cervical cancer – to a common form of childhood epilepsy.